查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1470599

白蛋白市场：按来源、类型、应用程式和最终用户 - 2024-2030 年全球预测

Albumin Market by Source (Animal Sources, Plant Sources), Type (Non-Recombinant, Recombinant), Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年白蛋白市场规模为65.3亿美元，预计2024年将达69.4亿美元，2030年将达102.3亿美元，复合年增长率为6.61%。

白蛋白是一种复杂且用途广泛的蛋白质，约占人体血浆总蛋白质的 50% 至 60%。它主要在肝臟中合成，在维持渗透压、结合和运输各种分子以及作为抗氧化剂等生理功能中发挥重要作用。白蛋白的重要性在于其对整体健康和福祉的多维贡献，使其成为评估个别疾病风险和临床状态的重要生物标记。由于烧烫伤的治疗和肝病的日益流行，患者需要定期供应 HSA 以维持正常的健康功能，白蛋白在临床实践中的使用正在增加，全球范围内白蛋白的使用正在加速。然而，源自混合人类血浆的 HSA 产品污染和传染性病原体传播相关的风险影响了白蛋白的使用。每个地区严格的产品认证监管指南也会影响白蛋白的商业化。市场开拓正在投资研发，探索创新的生产方法，例如基于植物的表达系统和微生物发酵工艺，可以以更低的成本生产高品质的白蛋白产品。生物技术的进步使得透过基因工程技术生产重组人体血清蛋白（rHA）成为可能，这正在创造新的机会。

主要市场统计
基准年[2023] 65.3亿美元
预测年份 [2024] 69.4亿美元
预测年份 [2030] 102.3亿美元
复合年增长率（%） 6.61%

由于特定治疗目的的永续性，消费者转向植物来源白蛋白。

白蛋白是血液中的重要蛋白质，在维持体液平衡和运输荷尔蒙、脂肪酸和药物方面发挥重要作用。白蛋白有两种主要来源：动物来源和植物来源。动物源性白蛋白可从牛血清 (BSA)、人类血浆 (HSA) 和 OV 白蛋白中取得。牛血清白蛋白 (BSA) 是诊断剂、疫苗和细胞培养基等多种应用的重要成分。 BSA 广泛用于诊断和研究，因为它价格实惠且容易获得。人类血清白蛋白 (HSA) 由于其与人类的高度生物相容性，在某些临床情况下是首选，例如药物输送系统和扩容疗法。 HSA 用于医疗紧急情况，例如烧烫伤治疗和心肺体外迴圈手术。近年来，植物来源替代品因其减少的环境影响和潜在的过敏原风险而成为一种永续的选择。植物来源白蛋白（包括米蛋白质和大豆蛋白）作为动物源性白蛋白的替代品在食品和饮料和饮料、药品和化妆品等应用中越来越受欢迎。相较之下，动物源性白蛋白已建立医学应用，儘管有疾病传播的风险。相较之下，植物来源白蛋白具有永续性，污染风险最小，但可能不适合特定的治疗目的。然而，消费者在动物性和植物性白蛋白之间进行选择的趋势取决于多种因素，例如预期用途、纯度要求、永续性问题以及与动物性蛋白质相关的潜在风险。

为了推广重组DNA技术，我们重点研究并开发了重组白蛋白作为合成蛋白。

非重组白蛋白是天然衍生的，主要来自人类和牛血清。由于其稳定蛋白质和酵素的能力，它被广泛应用于药物製剂、诊断剂、细胞培养基和医疗设备。基于需求的对非重组白蛋白的偏好源于其作为血液分离过程的产物而大量可用。重组白蛋白是使用基因工程表现系统（例如酵母或哺乳动物细胞）生产的。与非重组白蛋白相比，不存在病原体污染的风险，并且可以实现更稳定且永续的供应。重组白蛋白主要用于药物传递系统、疫苗、细胞治疗及再生医学。重组白蛋白是优选的，因为它是安全的，因为它不含有可以传播感染疾病的人类或动物来源的成分。

越来越关注应用疫苗生产和药物传输应用

白蛋白因其优异的保水性能而被广泛用作化妆品原料，可增强皮肤的保湿性和弹性。在生物技术产业中，白蛋白是支持细胞生长和增殖的培养基的重要组成部分。白蛋白在药物传递的应用利用其结合不同分子同时在各种条件下保持稳定的能力。白蛋白由于其乳化和发泡等功能而被用作多种产品的食品成分。基于白蛋白的疗法已用于治疗低白蛋白血症和烧烫伤等疾病。此外，疫苗製造商使用白蛋白作为稳定剂和防腐剂，以增加疫苗在储存和运输过程中的稳定性。

最终用户：医院和血库白蛋白的广泛最终用户

白蛋白的主要最终用户分为医院和诊所、製药和生技公司、学术研究机构和血库等第一级产业。这些设施将白蛋白产品用于多种目的，包括药物配製、诊断、疫苗生产、临床营养支持、细胞培养生长培养基补充和血液容量扩充。在医院和诊所，白蛋白经常用于治疗因严重或受伤引起的低白蛋白血症（一种以血液中白蛋白水平较低为特征的疾病）患者。它也用于在手术和涉及出血的创伤期间復苏体液。近年来，白蛋白作为肠外营养配方中的成分也受到欢迎，为口服摄取困难的患者提供必需的蛋白质。此外，它在血库中用作血浆扩张剂，以增加接受输血或因外伤、手术或其他情况而严重出血的患者的血液容量。白蛋白溶液有助于在这种关键条件下维持渗透压、稳定血液动力学参数并改善整体循环功能。

区域洞察

美洲白蛋白市场是由製药公司的投资推动的，这些公司正在大力投资研究和技术以开发先进的白蛋白配方。美国食品药物管理局（FDA）等监管机构实施了严格的品管，以确保白蛋白的安全标准。近年来，FDA 也批准了某些白蛋白产品。在美国和加拿大，正在研究重组 HSA 生产等技术进步，以减少对人类血浆捐赠白蛋白供应的依赖。由于新兴国家医疗保健支出的增加和医疗基础设施的改善，亚洲白蛋白市场正在迅速扩大，这些国家需要血浆衍生产品用于肝病治疗、手术和加护治疗支持等治疗目的。欧洲拥有成熟的消费基础和强大的製造能力，有潜力为全球白蛋白市场做出贡献。白蛋白在欧洲的使用主要集中在重症加护应用，例如败血症管理、容量替代疗法和治疗性血浆置换手术。欧洲药品管理局 (EMA) 负责监管欧盟 (EU) 内白蛋白的生产和分销。

FPNV定位矩阵

FPNV定位矩阵对于评估白蛋白市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对白蛋白市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.白蛋白市场规模及预测为何？

2.白蛋白市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.白蛋白市场的技术趋势和法规结构是什么？

4.白蛋白市场主要厂商的市场占有率是多少？

5.进入白蛋白市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 使用白蛋白作为慢性病发生率和术后手术部位感染的预测因子
      • 白蛋白作为食品和化妆品原料的使用正在迅速增加。
    • 抑制因素
      • 白蛋白可引起感染
    • 机会
      • 白蛋白奈米颗粒正在进行的研究活动
      • 白蛋白生产和精製方法的进展
    • 任务
      • 白蛋白生产和品管相关的严格规定
  • 市场区隔分析
    • 资料来源：由于某些治疗目的的永续性增强，消费者正在转向植物来源白蛋白。
    • 类型：加强重组白蛋白作为合成蛋白的研发，推动重组DNA技术
    • 应用：越来越关注疫苗製造和药物传输应用
    • 最终用户：医院和血库白蛋白的广泛最终用户
  • 市场趋势分析
    • 美洲各地的强劲投资补充了医疗技术的进步
    • 扩大生产，并制定安全法规来监控亚太地区的白蛋白产品
    • 欧洲、中东和非洲地区的重大研究活动和政府法规结构。
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章白蛋白市场：依来源分类

  • 动物起源
  • 植物来源

第七章白蛋白市场：依类型

  • 非重组
  • 重组

第八章白蛋白市场：依应用分类

  • 化妆品原料
  • 文化媒体
  • 药物输送
  • 食品添加物
  • 治疗性的
  • 疫苗成分

第 9 章 白蛋白市场：依最终使用者分类

  • 製药/生物技术
  • 调查机构

第10章美洲白蛋白市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区白蛋白市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲白蛋白市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Grifols 完成补偿肝硬化患者长期白蛋白（人类用白蛋白注射液）治疗的 3 期试验入组
    • Kedrion 的全球投资组合扩展到中国并开始提供人力资源
    • GC Biopharma 在巴西签署 9,000 万美元血液製品合约
    • Albumedix 与 Cell and Gene Therapy Catapult 签署合作协议
    • Albumedix 和 Valneva 扩大合作范围，纳入新核准的灭活 COVID-19 疫苗
    • American Regent 推出用于注射混悬液的紫杉醇蛋白结合颗粒（白蛋白结合）
    • SK Plasma 将耗资 2.5 亿美元在印尼建造血液製品工厂
    • Grifols 在扩建的都柏林工厂开设新的白蛋白工厂
    • Sartorius 收购 Albumedics：Albumin，一家先进重组治疗方法领域的公司
    • Tyvan Biologics Group 获得 3 亿美元融资

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-436901065945

[192 Pages Report] The Albumin Market size was estimated at USD 6.53 billion in 2023 and expected to reach USD 6.94 billion in 2024, at a CAGR 6.61% to reach USD 10.23 billion by 2030.

Albumin is a complex and versatile protein that constitutes approximately 50%-60% of the total protein content in human blood plasma. It is synthesized predominantly by the liver and plays an essential role in physiological functions, such as maintaining osmotic pressure, binding and transporting various molecules, and acting as an antioxidant. Albumin's importance lies in its multifaceted contributions to overall health and well-being, making it a significant biomarker for assessing an individual's disease risk and clinical status. The growing usage of albumin in clinical settings for the treatment of burns and the rising prevalence of liver diseases where patients require a regular supply of HSA to maintain proper health functions has accelerated the use of albumin worldwide. However, risks associated with contamination and transmission of infectious agents in HSA products sourced from pooled human plasma donations impact albumin usage. Stringent regulatory guidelines for product approvals in different regions also affect the commercialization of albumin. Market players are investing in research and development initiatives that explore innovative production methods, such as plant-based expression systems or microbial fermentation processes capable of yielding high-quality albumin products at lower costs. New opportunities are emerging with the evolution of biotechnological advancements that enable the production of recombinant human albumins (rHA) through genetic engineering techniques.

KEY MARKET STATISTICS
Base Year [2023] USD 6.53 billion
Estimated Year [2024] USD 6.94 billion
Forecast Year [2030] USD 10.23 billion
CAGR (%) 6.61%

Source: Consumer shift toward the plant-based albumins due to enhanced sustainability for specific therapeutic purposes.

Albumin, an important protein in the blood, plays essential role in maintaining fluid balance and transporting hormones, fatty acids, and drugs. The two primary albumin sources are animal-based and plant-based. Animal-derived albumin is obtained from bovine serum (BSA), human plasma (HSA), and ovalbumin. Bovine serum albumin (BSA) is a vital ingredient in various applications, such as diagnostic reagents, vaccines, and cell culture media. BSA is widely utilized in diagnostics and research due to its affordability and accessibility. Human serum albumin (HSA) is preferred for certain clinical situations, such as drug delivery systems or volume expansion therapies, due to its biocompatibility with humans. HSA is used in medical emergencies such as burns treatment and cardiopulmonary bypass surgery. In recent years, plant-based alternatives have emerged as a sustainable option for albumin production due to their reduced environmental impact and potential allergen risks. Plant-derived albumins, including rice and soy protein, are gaining popularity as alternatives to animal-derived counterparts for applications in food & beverage production, pharmaceuticals, and cosmetics. Comparatively, animal-derived albumins have established medical applications, although they pose a risk of disease transmission. In contrast, plant-based albumins offer sustainability with minimal contamination risk but may lack compatibility for specific therapeutic purposes. However, consumer trends to preferences to choose products between animal or plant-based albumins depend on factors such as application purpose, purity requirements, sustainability concerns, and potential risks associated with animal proteins.

Type: Enhanced emphasis on the research and development of recombinant albumin as a synthetic protein to promote recombinant DNA technology

Non-recombinant albumin is derived from natural sources, primarily human and bovine serum. It is widely used in pharmaceutical formulations, diagnostics, cell culture media, and medical devices due to its stabilizing properties for proteins and enzymes. The need-based preference for non-recombinant albumin arises from its availability in large quantities as a byproduct of blood fractionation processes. Recombinant albumin is produced using genetically engineered expression systems such as yeast and mammalian cells. It eliminates the risk of contamination with pathogens and offers a more consistent and sustainable supply compared to non-recombinant albumin. Recombinant albumin is mainly used in drug delivery systems, vaccines, cell therapy applications, and regenerative medicine. The preference for recombinant albumin is driven by its safety profile, as it is free from human or animal-derived components which may carry potential risks of transmitting infectious agents.

Application: Rising focus on vaccine manufacturing and drug delivery applications

Albumin is widely used as a cosmetic ingredient due to its excellent water-binding properties, enhancing skin hydration and elasticity. In the biotechnology industry, albumin serves as an essential component of culture media to support cell growth and proliferation. Albumin's drug delivery application capitalizes on its ability to bind various molecules while maintaining stability in different conditions. Albumin is employed in various products as a food ingredient due to its functional properties, such as emulsification and foaming. Albumin-based therapeutics are employed in treatments for conditions such as hypoalbuminemia and burns. Moreover, vaccine manufacturers use albumins as stabilizers or preservatives to enhance vaccine stability during storage and transportation.

End-User: Extensive end-users of the albumin in hospitals and blood banks

The major end-users of albumin can be categorized into primary sectors including, hospitals & clinics, pharmaceutical & biotechnology companies, academic research institutes, and blood banks. These establishments utilize albumin products for various purposes such as drug formulation, diagnostics, vaccine manufacturing, clinical nutrition support, cell culture growth media supplementation, and blood volume expansion. In hospitals & clinics Albumin is often employed to treat patients suffering from hypoalbuminemia - a condition characterized by low levels of albumin in the blood - caused by critical illness or injury. Additionally, it is utilized for fluid resuscitation during surgeries or trauma cases where blood loss has occurred. In recent years, albumin has also gained popularity as a component of parenteral nutrition formulas providing essential proteins needed for patients who are unable to consume food orally. Moreover, blood banks utilize it as a plasma expander to increase blood volume in patients undergoing blood transfusion or those with severe blood loss due to trauma, surgery, or other conditions. Albumin solutions can help maintain osmotic pressure, stabilize hemodynamic parameters, and improve overall circulatory function during such critical situations.

Regional Insights

The Americas albumin market is advancing, driven by investments by pharmaceutical companies investing heavily in research and technology to develop advanced albumin formulations. Regulatory bodies such as the Food and Drug Administration (FDA) in the U.S. enforce strict quality control measures to assure safety standards of albumin. The FDA has also given approval for certain albumin products in recent years. Technological advancements such as recombinant HSA production are being researched across the U.S. and Canada to potentially reduce dependency on human plasma donations for albumin supply. The Asian albumin market is experiencing rapid expansion fueled by increasing healthcare expenditure and improving medical infrastructure in emerging countries demanding plasma-derived products for therapeutic purposes, including liver disease treatment, surgeries, and intensive care support. Europe is a potential contributor to the global albumin market, with an established consumption base and robust manufacturing capabilities. The use of albumin in Europe is primarily focused on critical care applications such as sepsis management, volume replacement therapies, and therapeutic plasma exchange procedures. The European Medicines Agency (EMA) regulates the production and distribution of albumin within the European Union (EU).

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Albumin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Albumin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Albumin Market, highlighting leading vendors and their innovative profiles. These include Aadi Bioscience, Inc., Agilent Technologies, Inc., Akron Biotech, Atlantis Bioscience Pte Ltd., Avantor Inc., Baxter International Inc., Becton, Dickinson and Company, Bio Products Laboratory Ltd., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenix Inc. Pvt. Ltd., Biophyll GmbH, Biorbyt Ltd., Biowest SAS, Boston BioProducts Inc., Bristol-Myers Squibb Company, CENTURION PHARMA Ilac Sanayi ve Ticaret A.S., China Biologic Products Holdings, Inc. by Taibang Biologic Group, CSL Limited, Dem Ilac, F. Hoffmann-La Roche AG, GC Biopharma Corp., Glentham Life Sciences Limited, Grifols SA, InVitria, InVitroCare Inc., Kedrion S.p.A, Kraeber & Co. GmbH, Lazuline Biotech Private Limited, LGC Science Group Holdings Limited, Merck KGaA, Midas Pharma GmbH, Octapharma AG, Promega Corporation, Prospec-Tany Technogene Ltd., Rockland Immunochemicals Inc., Rocky Mountain Biologicals, LLC, Sartorius AG, Serion GmbH, SK Plasma, Takeda Pharmaceuticals Company Limited, Thermo Fisher Scientific Inc., Ventria Bioscience Inc., and VitroScient.

Market Segmentation & Coverage

This research report categorizes the Albumin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Source
    • Animal Sources
      • Bovine Serum Albumin
      • Human Serum Albumin
      • Ovalbumin
    • Plant Sources
  • Type
    • Non-Recombinant
    • Recombinant
  • Application
    • Cosmetic Ingredient
    • Culture Media
    • Drug Delivery
    • Food Ingredient
    • Therapeutic
    • Vaccine Ingredient
  • End User
    • Pharmaceutical & Biotechnology
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Albumin Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Albumin Market?

3. What are the technology trends and regulatory frameworks in the Albumin Market?

4. What is the market share of the leading vendors in the Albumin Market?

5. Which modes and strategic moves are suitable for entering the Albumin Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Incidence of chronic diseases and use of albumin as a predictor of postoperative surgical site infections
      • 5.1.1.2. Surging utilization of albumin as a food and cosmetic ingredient
    • 5.1.2. Restraints
      • 5.1.2.1. Potential of albumin to cause transmission of infections
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research activities regarding albumin nanoparticles
      • 5.1.3.2. Advancements in albumin production and purification methods
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with albumin manufacturing and quality control
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source: Consumer shift toward the plant-based albumins due to enhanced sustainability for specific therapeutic purposes.
    • 5.2.2. Type: Enhanced emphasis on the research and development of recombinant albumin as a synthetic protein to promote recombinant DNA technology
    • 5.2.3. Application: Rising focus on vaccine manufacturing and drug delivery applications
    • 5.2.4. End-User: Extensive end-users of the albumin in hospitals and blood banks
  • 5.3. Market Trend Analysis
    • 5.3.1. Medical technology advancements supplemented with robust investment across the Americas
    • 5.3.2. Expanding production coupled with availability of safety regulations to monitor albumin products in APAC region
    • 5.3.3. Significant research activities and government regulatory framework in the EMEA region.
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Albumin Market, by Source

  • 6.1. Introduction
  • 6.2. Animal Sources
  • 6.3. Plant Sources

7. Albumin Market, by Type

  • 7.1. Introduction
  • 7.2. Non-Recombinant
  • 7.3. Recombinant

8. Albumin Market, by Application

  • 8.1. Introduction
  • 8.2. Cosmetic Ingredient
  • 8.3. Culture Media
  • 8.4. Drug Delivery
  • 8.5. Food Ingredient
  • 8.6. Therapeutic
  • 8.7. Vaccine Ingredient

9. Albumin Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biotechnology
  • 9.3. Research Institutes

10. Americas Albumin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Albumin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Albumin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Grifols Completes Enrollment In Phase 3 Study Of Long-Term Albutein (Albumin-Human Injection) Therapy For Patients With Decompensated Cirrhosis
    • 13.3.2. Kedrion's Global Portfolio Expands To China To Supply Human Albumin
    • 13.3.3. GC Biopharma inks USD 90mn deal for blood products in Brazil
    • 13.3.4. Albumedix Enters into Collaboration Agreement with Cell and Gene Therapy Catapult
    • 13.3.5. Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine
    • 13.3.6. American Regent Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
    • 13.3.7. SK Plasma to build USD 250m blood products plant in Indonesia
    • 13.3.8. Grifols Inaugurates New Albumin Plant At its Expanding Dublin Site
    • 13.3.9. Sartorius acquires Albumedix: A player in advanced therapies based on recombinant albumin
    • 13.3.10. Taibang Biologic Group Secures Equity Raising of USD 300 Million

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ALBUMIN MARKET RESEARCH PROCESS
  • FIGURE 2. ALBUMIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALBUMIN MARKET DYNAMICS
  • FIGURE 7. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ALBUMIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. ALBUMIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALBUMIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ALBUMIN MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALBUMIN MARKET SIZE, BY OVALBUMIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ALBUMIN MARKET SIZE, BY OVALBUMIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALBUMIN MARKET SIZE, BY NON-RECOMBINANT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ALBUMIN MARKET SIZE, BY NON-RECOMBINANT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ALBUMIN MARKET SIZE, BY COSMETIC INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ALBUMIN MARKET SIZE, BY COSMETIC INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ALBUMIN MARKET SIZE, BY FOOD INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ALBUMIN MARKET SIZE, BY FOOD INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 355. POLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 356. POLAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 357. POLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 358. POLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 365. QATAR ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 366. QATAR ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 367. QATAR ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 368. QATAR ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 375. RUSSIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 376. RUSSIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 377. RUSSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 378. RUSSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 379. RUSSIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 380. RUSSIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 381. RUSSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 382. RUSSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 383. RUSSIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 384. RUSSIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 385. SAUDI ARABIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 386. SAUDI ARABIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 387. SAUDI ARABIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 388. SAUDI ARABIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 389. SAUDI ARABIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 390. SAUDI ARABIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 391. SAUDI ARABIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 392. SAUDI ARABIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 393. SAUDI ARABIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 394. SAUDI ARABIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 395. SOUTH AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 396. SOUTH AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 397. SOUTH AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 398. SOUTH AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 399. SOUTH AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 400. SOUTH AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 401. SOUTH AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 402. SOUTH AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 403. SOUTH AFRICA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 404. SOUTH AFRICA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 405. SPAIN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 406. SPAIN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 407. SPAIN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 408. SPAIN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 409. SPAIN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 410. SPAIN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 411. SPAIN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 412. SPAIN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)

TA